Adaptimmune Therapeutics Plc ADR (ADAP) is destined for greater heights as its last quarter sales were 128,230 K
On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) opened lower -2.24% from the last session, before settling in for the closing price of $0.84. Price